EYE MUSCLE MEMBRANE REACTIVE ANTIBODIES ARE NOT DETECTED IN THE SERUM OR IMMUNOGLOBULIN FRACTION OF PATIENTS WITH THYROID-ASSOCIATED OPHTHALMOPATHY USING AN ELISA AND CRUDE MEMBRANES

被引:16
作者
KAPUSTA, M [1 ]
SALVI, M [1 ]
TRILLER, H [1 ]
GARDINI, E [1 ]
BERNARD, N [1 ]
WALL, JR [1 ]
机构
[1] MONTREAL GEN HOSP,RES INST,THYROID RES UNIT,1650 CEDAR AVE,MONTREAL H3G 1A4,QUEBEC,CANADA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
64kDa antigen; Enzyme-linked immunosorbent assay (ELISA); Eye muscle antibodies; Ophthalmopathy; SDS-PAGE;
D O I
10.3109/08916939009041048
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We tested sera and purified immunoglobulin (Ig) fractions from patients with autoimmune thyroid disorders (AITD), with and without ophthalmopathy, and normal subjects, for the presence of antibodies reactive with eye muscle membrane antigens in an optimized enzyme-linked immunosorbent assay (ELISA). We found no correlation between ELISA results and the presence or severity of ophthalmopathy in patients with AITD for either serum or Ig, and there were no significant differences between the mean values (± SE) for the three groups (AITD with ophthalmopathy, AITD without ophthalmopathy and normals) for either serum or Ig. In contrast Ig from 8 of 19 (45% patients with thyroid-associated ophthalmopathy reacted with a 64 kDa eye muscle membrane antigen in SDS-polyacrylamide gel elec-tropohoresis and Western blotting, while tests were positive in only one of the 8 patients with AITD without eye disease and in none of the 8 normal subjects. The presence of antibodies to a 64kDa antigen in immunoblotting did not correlate with the levels of antibodies measured in ELISA. We conclude that the ELISA, incorporating crude membrane fractions as antigen, is not useful as a clinical test for eye muscle autoantibodies. © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 15 条
[1]  
Wall J.R., How J., Salvi M., Hiromatsu Y., Can endocrine exophthalmos now be viewed as separate from thyroid autoimmunity, Bailliere's Clin Immunol All, 1, pp. 141-163, (1987)
[2]  
Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J.R., Demonstration of a circulating autoanti-body against a soluble eye muscle antigen in Graves' ophthalmopathy, Lancet, 2, pp. 1353-1356, (1982)
[3]  
Kendall-Taylor P., Atkinson S., Holcombe M., A specific IgG in Graves' ophthalmopathy and its relation to retro-orbital and thyroid autoimmunity, Br Med J, 288, pp. 1183-1186, (1984)
[4]  
Faryna M., Nauman J., Gardas A., Measurement of autoantibodies against human eye muscle plasma membranes in Graves' ophthalmopathy, Br Med J, 290, pp. 191-192, (1985)
[5]  
Mengistu M., Laryea E., Miller A., Wall J.R., Clinical significance of a new autoantibody against a human eye muscle soluble antigen detected by immunofluorescence, Clin Exp Immunol, 65, pp. 19-27, (1986)
[6]  
Miller A., Sikorska H., Salvi M., Wall J.R., Evaluation of an enzyme-linked immunosorbent assay for the measurement of autoantibodies against eye muscle membrane antigens in Graves' ophthal-mopathy, Acta Endocrinol (Kbh), 113, pp. 514-522, (1986)
[7]  
Werner S.C., Modification of the classification of the eye changes in Graves' disease: recommendations of an Ad Hoc Committee of the American Thyroid Association, J Clin Endocrinol Metab, 44, pp. 203-204, (1977)
[8]  
Laemmli U.K., Cleavage of structural proteins during assembly of the head of bacteriophage T4, Nature, 227, pp. 680-684, (1970)
[9]  
Salvi M., Fukazawa H., Bernard H., Hiromatsu Y., How J., Wall J.R., Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders, Endocrine Rev, 9, pp. 450-466, (1988)
[10]  
Hiromatsu Y., Fukazawa H., How J., Wall J.R., Antibody-dependent cell-mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves' ophthalmopathy-roles of Class II MHC antigen expression and γ-interferon action on effector and target cells, Clin Exp Immunol, 70, pp. 597-603, (1987)